MedClone Inc. announced last week that it has received anotice of allowance for University of California patentapplication No. 07/772,434 from the U.S. Patent andTrademark Office (PTO).
Privately held MedClone of Los Angeles is the exclusiveworldwide licensee of the patent, which claims a noveldiagnostic testing technology for rheumatoid factors (fordiagnosing and managing rheumatoid arthritis).
(c) 1997 American Health Consultants. All rights reserved.